dr. grivas on potential combinations with cabazitaxel in prostate cancer
Published 4 years ago • 157 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
1:35
dr. grivas on cabazitaxel/enzalutamide in mcrpc
-
1:03
dr. grivas on combination strategies in genitourinary cancer
-
0:52
dr. robert dreicer on potential combinations in prostate cancer
-
2:03
dr. grivas on the role of targeted therapy in prostate cancer
-
4:06
combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer
-
7:09
cabazitaxel use in metastatic prostate cancer
-
1:17
dr. grivas on promising combination therapies in bladder cancer
-
1:30
cabazitaxel impacts sequencing strategies in prostate cancer
-
3:12
cabazitaxel (jevtana) for progressive metastatic prostate cancer after taxotere
-
6:16
evolution of treatment for metastatic castration-resistant prostate cancer
-
1:37
cabazitaxel rechallenge in patients with metastatic castration resistant prostate cancer
-
1:10
dr. daniel petrylak discusses chemotherapy in prostate cancer
-
2:32
dr. sweeney on the optimal use of cabazitaxel
-
1:53
nicholas vogelzang, md, explains how cabazitaxel should be used in various lines of treatment in mpc
-
2:06
mcrpc: cabazitaxel re-challenge
-
4:34
card: cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer
-
0:19
copy of dr. grivas on promising combination therapies in bladder cancer
-
2:56
therap: lupsma versus cabazitaxel for prostate cancer
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide